A poor prognosis has been documented for pediatric patients with gliomas overexpressing EPHA7 [86], alveolar-type rhabdomyosarcomas overexpressing EPHB4 [75,81], and osteosarcomas presenting ephrin-A4 cytoplasmic expression [124]. This evidence concerns the gene EPHB4 and central nervous system cancer.